Evidence map›Paper›PMID 32883293›Full record

ReviewMicrobial cell factories2020

Bacillus subtilis: a universal cell factory for industry, agriculture, biomaterials and medicine.

Yuan Su, Chuan Liu, Huan Fang, Dawei Zhang

Abstract readReview
In one paragraph

Review in Microbial cell factories, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 203 papers.

0numbers the graph read from it
0cells of the map it votes in
203citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

203 citing papers in PubMed.

  1. Trial
  2. Enhanced production of l-histidine inSynthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Animals : an open access journal from MDPI · 2026
    Review
  9. Article
  10. Article
  11. Development of Bacillus subtilis cell factories for nutraceuticals production.World journal of microbiology & biotechnology · 2026
    Review
  12. A deformableMaterials today. Bio · 2026
    Article
  13. Article
  14. Article
  15. Anti-inflammatory effect ofJournal of animal science and technology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Enhanced microbial production of pyridoxine (Vitamin BSynthetic and systems biotechnology · 2026
    Article

143 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuan SuCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Chuan LiuTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China.
Huan FangTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China.
Dawei ZhangTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China. zhang_dw@tib.cas.cn.ORCID http://orcid.org/0000-0001-5555-6151

Funding

National Key R&D Program of China 2018YFA0901600Science and Technology Service Network (STS) Initiative of the Chinese Academy of Sciences (CAS) KFJ-STS-ZDTP-065the Tianjin Science Fund for Distinguished Young Scholars 17JCJQJC45300
6 · The paper itself

Abstract

Due to its clear inherited backgrounds as well as simple and diverse genetic manipulation systems, Bacillus subtilis is the key Gram-positive model bacterium for studies on physiology and metabolism. Furthermore, due to its highly efficient protein secretion system and adaptable metabolism, it has been widely used as a cell factory for microbial production of chemicals, enzymes, and antimicrobial materials for industry, agriculture, and medicine. In this mini-review, we first summarize the basic genetic manipulation tools and expression systems for this bacterium, including traditional methods and novel engineering systems. Secondly, we briefly introduce its applications in the production of chemicals and enzymes, and summarize its advantages, mainly focusing on some noteworthy products and recent progress in the engineering of B. subtilis. Finally, this review also covers applications such as microbial additives and antimicrobials, as well as biofilm systems and spore formation. We hope to provide an overview for novice researchers in this area, offering them a better understanding of B. subtilis and its applications.

Indexed as

Industrial MicrobiologyBacillus subtilisBacterial ProteinsBiocompatible MaterialsBiological ProductsEnzymesGene Expression Regulation, BacterialGenetic EngineeringRecombinant ProteinsVitaminsBacterial ProteinsBiocompatible MaterialsBiological ProductsEnzymesRecombinant ProteinsVitaminsAntimicrobialsBacillus subtilisBiochemicalsBiofilmsEnzymesGenetic manipulationProtein expression

Identifiers

PMID32883293
PMCPMC7650271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.